Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
bone marrow derived mesenchymal stem cells (1 trial)
Ischemia (Phase 2)
Retinal Diseases (Phase 2)
Trials (1 total)
Trial APIs (1 total)